[HTML][HTML] Influence of body mass index on clinical outcomes in venous thromboembolism: insights from GARFIELD‐VTE

JI Weitz, AE Farjat, W Ageno, AGG Turpie… - Journal of Thrombosis …, 2021 - Elsevier
Background There is limited information on the influence of body mass index (BMI) on
clinical outcomes in patients with venous thromboembolism (VTE). Objectives Investigate …

Body mass index and mortality in patients with acute venous thromboembolism: findings from the RIETE registry

R Barba, A Zapatero, JE Losa, V Valdes… - … of Thrombosis and …, 2008 - Wiley Online Library
Background: There is little information on the influence of body mass index (BMI) on
mortality in patients with acute venous thromboembolism (VTE). Patients and methods …

Anticoagulation treatment and outcomes of venous thromboembolism by weight and body mass index: insights from the veterans health administration

AC Perino, J Fan, S Schmitt, JD Guo… - … Quality and Outcomes, 2021 - Am Heart Assoc
Background: Consensus statements have recommended against the use of direct oral
anticoagulants (DOACs) in venous thromboembolism (VTE) for patients≥ 120 kg and≥ 40 …

[HTML][HTML] The influence of extreme body weight on clinical outcome of patients with venous thromboembolism: findings from a prospective registry (RIETE)

R Barba, J Marco, H Martin‐Alvarez, P Rondon… - Journal of Thrombosis …, 2005 - Elsevier
Background: Data evaluating the safety of using weight‐based dosing of low‐molecular‐
weight heparin (LMWH) in either underweight or obese patients with venous …

Safety and efficacy of direct oral anticoagulants across body mass index groups in patients with venous thromboembolism: a retrospective cohort design

RM Cardinal, F D'Amico, A D'Addezio, K Dakers… - Journal of Thrombosis …, 2021 - Springer
Current literature on the safety and efficacy of direct oral anticoagulants (DOACs) in patients
of extreme weights are limited, however, they are still being prescribed in these populations …

Obesity paradox in patients with deep venous thrombosis

A El-Menyar, M Asim… - Clinical and Applied …, 2018 - journals.sagepub.com
We aimed to investigate the association between obesity and deep venous thrombosis
(DVT) in a country with a high prevalence of obesity. This is a retrospective cohort study of …

Effectiveness and safety of apixaban and rivaroxaban for acute venous thromboembolism therapy in patients with extremes in bodyweight

WE Wysokinski, DA Froehling… - European Journal of …, 2020 - Wiley Online Library
Objectives To investigate the association of extremes in bodyweight (EBW) and outcomes in
patients with acute venous thromboembolism (VTE). Recurrent VTE, major bleeding, and …

[HTML][HTML] Obesity is not associated with recurrent venous thromboembolism in elderly patients: Results from the prospective SWITCO65+ cohort study

C Mueller, A Limacher, M Mean, N Rodondi, D Aujesky - Plos one, 2017 - journals.plos.org
Background Whether obesity is associated with recurrent venous thromboembolism (VTE) in
elderly patients is unknown. Objectives To examine the association between two obesity …

[HTML][HTML] Obesity as a risk factor for venous thromboembolism recurrence: a systematic review

P Ntinopoulou, E Ntinopoulou, IV Papathanasiou… - Medicina, 2022 - mdpi.com
Background and Objectives: Venous thromboembolism (VTE) encompasses Deep Venous
Thrombosis (DVT) and Pulmonary Embolism (PE). The duration of anticoagulant therapy …

[HTML][HTML] Overall and abdominal obesity in relation to venous thromboembolism

S Yuan, M Bruzelius, Y Xiong, N Håkansson… - Journal of Thrombosis …, 2021 - Elsevier
Background Abdominal obesity has been shown to be a superior measure over overall
obesity for detecting cardiovascular risk. Objective We conducted this study to compare the …